Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.58 |
| ▸ | CA2 | P00918 | 3/20 | 0.58 |
| ▸ | CA12 | O43570 | 2/20 | 0.58 |
| ▸ | CA7 | P43166 | 2/20 | 0.58 |
| ▸ | CA9 | Q16790 | 2/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.58 |
| ▸ | ESR1 | P03372 | 1/20 | 0.58 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | MAOA | P21397 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.51 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.51 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.51 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 4/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13199136 | 0.91 | TSHR (0.49) | CA1CA2CA12CA7CA9 | |
| SCHEMBL12003891 | 0.88 | MAOB (0.47) | CA1CA2CA12CA7CA9 | |
| SCHEMBL12004362 | 0.88 | SRD5A2 (0.47) | CA1CA2CA12CA7CA9 | |
| SCHEMBL12019025 | 0.86 | HDAC4 (0.47) | CA1CA2CA12CA7CA9 | |
| SCHEMBL15942603 | 0.86 | CA1 (0.58) | CA1CA2CA12CA7CA9 | |
| SCHEMBL5003336 | 0.86 | NPSR1 (0.47) | LMNAKMT2ATSHRHTTSMN1; SMN2 | |
| SCHEMBL13199166 | 0.86 | TSHR (0.46) | LMNAMEN1KMT2ATSHRPDK2 | |
| SCHEMBL17583195 | 0.86 | NPSR1 (0.51) | CYP1A2MEN1KMT2ATSHRMAPT | |
| SCHEMBL668192 | 0.86 | CA12 (0.61) | CA1CA2CA12CA7CA9 | |
| SCHEMBL31306426 | 0.84 | CA12 (0.55) | CA1CA2CA12CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8802886-B2 | Method for producing aromatic difluoroacetic acid ester | CENTRAL GLASS COMPANY, LIMITED (JP) | 2014-08-12 | — | — | US | disclosed |
| US-8802886-B2 | Method for producing aromatic difluoroacetic acid ester | CENTRAL GLASS COMPANY, LIMITED (JP) | 2014-08-12 | — | — | US | disclosed |
| EP-2502898-A1 | PREPARATION METHOD FOR AROMATIC DIFLUOROACETIC ACID ESTER | Central Glass Company, Limited (JP) | 2012-09-26 | — | — | EP | disclosed |
| US-20120220795-A1 | METHOD FOR PRODUCING AROMATIC DIFLUOROACETIC ACID ESTER | CENTRAL GLASS COMPANY, LIMITED (JP) | 2012-08-30 | — | — | US | disclosed |
| US-20100216758-A1 | Pyridone Compounds | MSD K.K. (JP) | 2010-08-26 | — | — | US | disclosed |
| EP-1916239-A1 | PYRIDONE COMPOUND | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2008-04-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100216758-A1 | Pyridone Compounds | NPY1R, MC5R, MC1R | CA1 4878/4885CA2 4358/4885CA12 4875/4885 |
| US-20120220795-A1 | METHOD FOR PRODUCING AROMATIC DIFLUOROACETIC ACID ESTER | DDC, AADAC, FNTB | CA1 115/4885CA2 184/4885CA12 256/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.